The first patient with dry age-related macular degeneration has received stem cells transplants in a clinical trial.
"This trial signifies an exciting extension of our on-going clinical research with neural stem cells from disorders of the brain and spinal cord to now include the eye," said Stephen Huhn, a StemCells vice president.
Click here to read more.
No comments:
Post a Comment